Delivery Lumen Access Device for Vasectomy
What You Need to Know Before You Apply
What is the purpose of this trial?
This study will evaluate the safety and usability of the Delivery Lumen Access Device (DLAD) in accessing the vas deferens in up to 30 healthy males. This is a prospective, non-randomized, open label interventional study.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the study team or your doctor.
Is the Delivery Lumen Access Device for vasectomy safe for humans?
The safety of vasectomy techniques, including those using devices like the Delivery Lumen Access Device, generally shows low complication rates. Common issues can include minor bleeding, infection, and pain, but long-term negative effects are not proven. The experience of the surgeon and the technique used are important for minimizing risks.12345
How does the Delivery Lumen Access Device treatment for vasectomy differ from other treatments?
The Delivery Lumen Access Device for vasectomy is unique because it potentially offers a reversible method of blocking the vas deferens (the tube that carries sperm), unlike traditional vasectomy methods that are typically permanent. This device uses silicone plugs that can be removed to restore sperm flow, providing a novel option for men who may want to reverse the procedure in the future.26789
Who Is on the Research Team?
Darlene Walley
Principal Investigator
Next Life Sciences
Are You a Good Fit for This Trial?
This trial is for healthy men aged 18 to 65 who have decided to get a vasectomy. Participants must be in good health as confirmed by medical history and physical examination, agree to the study's procedures by signing a consent form, and be considered suitable for a vasectomy as long-term contraception.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo the DLAD procedure during their vasectomy to test the device's safety and usability
Follow-up
Participants are monitored for safety and effectiveness after the procedure, including a 14-day post-procedure check for adverse events
What Are the Treatments Tested in This Trial?
Interventions
- Delivery Lumen Access Device
Find a Clinic Near You
Who Is Running the Clinical Trial?
Next Life Sciences
Lead Sponsor
Southern Star Research
Industry Sponsor